Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Type I plasminogen activator inhibitor 4G allele frequency is associated with chronic venous insufficiency.

The Journal of international medical research - 1 Jan 2000

Katrancioglu N, Manduz S, Ozen F, Yilmaz M Birhan, Karahan O, Ozdemir O, Berkan O

Abstract excerpt

Chronic venous insufficiency (CVI) is a common disease associated with poor quality of life. Genetic polymorphisms causing coagulation abnormalities may account for some of the CVI pathogenesis. Type I plasminogen activator inhibitor (PAI-1) is responsible for fibrinolytic system regulation, and plasma levels of PAI-1 are strongly correlated with PAI-1 4G/5G gene polymorphism. The association between PAI-1 4G/5G...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Chronic Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Demography

Share to Gene Frequency

Share to Genetic Predisposition to Disease

Share to Plasminogen Activator Inhibitor 1

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 20926026
DOI: 10.1177/147323001003800435

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Type I plasminogen activator inhibitor 4G allele frequency is associated with chronic venous insufficiency.PMID 20926026Read ↗

Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.Semantic proximity Read ↗

The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia.Semantic proximity Read ↗

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis.Semantic proximity Read ↗

Plasminogen Activator Inhibitor-1 Levels and PolymorphismsSemantic proximity Read ↗

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.Semantic proximity Read ↗

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosisSemantic proximity Read ↗

4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.Semantic proximity Read ↗

PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.Semantic proximity Read ↗

The involvement of genetic factors in chronic venous insufficiency.Semantic proximity Read ↗

The 4G/5G Sequence Polymorphism in the Promoter of Plasminogen Activator Inhibitor-1 (PAI-1) Gene: Relationship to Plasma PAI-1 Level in Venous ThromboembolismSemantic proximity Read ↗

A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.